NDC 0074-1065 – Skyrizi
· Kit · Intravenous
Product NDC0074-1065
Product details
- Brand name
- Skyrizi
- Generic name
- Risankizumab-rzaa
- Labeler
- AbbVie Inc.
- Dosage form
- Kit
- Route
- Intravenous
- Marketing category
- BLA · BLA761105
- Marketed since
- September 23, 2022
- Listing expires
- December 31, 2027
Active ingredients
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0074-1065-01 | 1 KIT in 1 CARTON (0074-1065-01) * 1.2 mL in 1 CARTRIDGE (0074-1066-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-01) | Sep 23, 2022 |
| 0074-1065-02 sample | 1 KIT in 1 CARTON (0074-1065-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-01) | Sep 23, 2022 |
Other Skyrizi products
- 0074-1070 · Kit · AbbVie Inc.
- 0074-7040 · Kit · AbbVie Inc.
- 0074-7042 · Kit · AbbVie Inc.
- 0074-1050 Risankizumab 150 mg/mL · Injection · AbbVie Inc.
- 0074-2100 Risankizumab 150 mg/mL · Injection · AbbVie Inc.
- 0074-4059 Risankizumab 55 mg/.37mL · Injection, Solution · AbbVie Inc.
- 0074-5015 Risankizumab 600 mg/10mL · Injection · AbbVie Inc.
- 0074-8300 Risankizumab 180 mg/1.2mL · Injection · AbbVie Inc.
- 0074-8350 Risankizumab 180 mg/1.2mL · Injection · AbbVie Inc.